SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
US: FDA approval not reviewed here
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Ongoing, no longer enrolling
Registry enrollment: 82 participants
Study ages: 6 Years to 12 Years
Results posted Nov 16, 2026
Read trial record and resultsChecked Nov 17, 2026